The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...
Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...
The current status of the Biosecure Act is that it was passed by the US House of Representatives on Sep 9, with a vote of ...
Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm ...
The partners are preparing for commercialization of the lung cancer drug limertinib as they await an approval decision from China’s National Drug Administration.
Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a value of $22.6 billion dollars by next year (2025). One area it is thriving ...
In today’s complex regulatory environment, ensuring weighing data integrity is not just a best practice but a necessity for compliance. However, the benefits of maintaining robust data integrity go ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback